Search Results

Innovative Medicine

May 25, 2011

Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)

Innovative Medicine

May 24, 2011

Veridex Launches CELLTRACKS® Circulating Melanoma Cell Kit For Research Use

Automated process gives researchers a simple, reliable method to capture and count circulating melanoma cells

Innovative Medicine

May 20, 2011

FDA Approves EDURANT™ (rilpivirine) For Use in Treatment-Naïve Adults with HIV-1

Third medication for Tibotec Therapeutics HIV treatment portfolio

Innovative Medicine

May 18, 2011

Schizophrenia24x7.com: A New, Interactive Website for Patients and Carers

Innovative Medicine

May 9, 2011

Phase 2b Data Show Treatment With STELARA® Induced and Maintained Clinical Response in Patients With Moderate to Severe Crohn’s Disease

Study Findings Show Efficacy of STELARA in Patients Who Previously Had Inadequate Response to Tumor Necrosis Factor Antagonists

Innovative Medicine

May 9, 2011

“Living with Schizophrenia” Documentary Shines Spotlight on People with Schizophrenia: A Misunderstood and Stigmatized Illness

Film provides powerful insights through compelling first-person life stories

Innovative Medicine

May 9, 2011

New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis

Study Findings Demonstrate Clinical Response with REMICADE in Pediatric Patients Who Have Not Responded to Conventional Therapy

Innovative Medicine

April 29, 2011

“George Canyon & Friends Diabetes Heroes Tour” Brings Message of Hope and Inspiration to Canadians Living with Type 1 Diabetes

Innovative Medicine

April 28, 2011

ZYTIGA™ (Abiraterone Acetate) Receives FDA Approval For Treatment Of Metastatic Prostate Cancer After Priority Review

First Once-Daily, Oral Treatment for Metastatic Prostate Cancer Inhibits Androgen Production at All Three Sources

Innovative Medicine

August 31, 2010

Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study

Latest Results from EINSTEIN Program Presented at European Society of Cardiology Congress

Search Results

No Results

Search Results

You are now leaving jnj.com/innovativemedicine